The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment.

Piątkowska-Chmiel I, Gawrońska-Grzywacz M, Popiołek Ł, Herbet M, Dudka J

Open source

DOI
10.1038/s41598-022-10187-y
Published
2022 Apr 25
Container
Scientific reports
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-10187-y,
  title = {The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment.},
  author = {Piątkowska-Chmiel I and Gawrońska-Grzywacz M and Popiołek Ł and Herbet M and Dudka J},
  year = {2022},
  journal = {Scientific reports},
  doi = {10.1038/s41598-022-10187-y},
  url = {https://doi.org/10.1038/s41598-022-10187-y}
}

RIS

TY  - JOUR
TI  - The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment.
AU  - Piątkowska-Chmiel I
AU  - Gawrońska-Grzywacz M
AU  - Popiołek Ł
AU  - Herbet M
AU  - Dudka J
PY  - 2022
JO  - Scientific reports
DO  - 10.1038/s41598-022-10187-y
UR  - https://doi.org/10.1038/s41598-022-10187-y
ER  -

APA

I, P., M, G., Ł, P., M, H., & J, D. (2022). The novel adamantane derivatives as potential mediators of inflammation and neural plasticity in diabetes mice with cognitive impairment.. Scientific reports. https://doi.org/10.1038/s41598-022-10187-y

Source records